IMR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - AC Immune SA

Watchlist Manager

Watchlist

Price: 2.075 EUR -3.04% Market Closed

Market Cap: €205.8m

	AC Immune SA F:IMR	CH
	Stora Enso Oyj F:ENUS	FI
B	Brown-Forman Corp DUS:BF5B	US
P	Public Service Enterprise Group Inc SWB:PSE	US

Profitability Summary

AC Immune SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 749%

Negative 3Y Average Operating Margin

-801%

Operating Margin is Increasing

-1 771% > -1 749%

Negative Net Margin

-1 789%

Negative 3Y Average Net Margin

-806%

Declining Net Margin

-1 766% > -1 789%

Negative Free Cash Flow Margin

-1 895%

Negative 3Y Average Free Cash Flow Margin

-601%

Declining Free Cash Flow Margin

-1 734% > -1 895%

Negative ROE

-105%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-91%

ROIC is Increasing

-112% > -104%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.